Tg Therapeutics, Inc.NASDAQ: TGTX

TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting

· Issued by Tg Therapeutics, Inc.
Watch Tg Therapeutics explain itTG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call · Replay · Aug 3

UNITY-CLL: U2 significantly improved progression-free survival over obinutuzumab plus chlorambucil (HR=0.54, p